It has been proved that AIL inhibits the PI3K/AKT signaling pathway by lowering the PI3K and AKT phosphorylation in many tumors, thereby playing an anti-tumor role (Ding et al., 2020). This evidence concerns the gene AKT1 and neoplasm.